Day 3: Top Takeaways From ASCO24

Day 3: Top Takeaways From ASCO24

Suivant

What Challenges Will Oncologists Face in 2026?

Dr. Monty Pal and Dr. Jason Westin discuss the federal funding climate for cancer research and the persistent problem of drug shortages, two of the major concerns facing the oncology community in 2026. TRANSCRIPT Dr. Monty Pal: Hello and welcome to the ASCO Daily News Podcast. I ...  Afficher plus

What Frontline Treatment Should Be Used in Advanced Ovarian Cancer?

<span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;">Dr. Linda Duska and Dr. Kathleen Moore discuss key studies in the evolving controversy over radical upfront surgery versus neoadjuvant chemotherapy in advanced ovarian cancer.</span>

<span style= ...

  Afficher plus

Épisodes Recommandés

Podcast 300: NADIM II trial offers “quite exciting” results in lung cancer
Clinical Conversations

A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE.

We’re back with another interview from this year’s IASLC conference.

This time, Christine Sadlowski and Dr. Julia Rotow interview Dr. Mar ...

  Afficher plus

Management of Stage III NSCLC Rapid Recommendation Update
ASCO Guidelines

Dr. Navneet Singh joins us again, this time to discuss the rapid recommendation update for stage III non-small cell lung cancer, incorporating updated data presented at the 2023 ASCO Annual Meeting. He discusses the new trials that prompted the guideline update and updated recomm ...  Afficher plus

327. Cardio-Oncology: Interventional CardioOncology with Dr. Cezar Iliescu
Cardionerds: A Cardiology Podcast

CardioNerds CardioOncology Series Co-Chairs, Dr. Teodora Donisan and Dr. Dinu Balanescu, and FIT Lead Dr. Bala Pushparaji discuss Interventional CardioOncology with Prof. Cezar Iliescu. In this episode, we discuss the spectrum of cardiovascular diseases encountered by the inte ...  Afficher plus

Review of the GISSI-2 Trial
Cardiology Trials

Lancet 1990;336:65-71.

Background Large trials up to this point had established the role of thr ...

  Afficher plus